Company Profile

Spark Neuro Inc
Profile last edited on: 5/26/2023      CAGE: 63JN7      UEI: GW3LFLL3NWT3

Business Identifier: Quantifying brain data for better clinical care and therapeutic discovery
Year Founded
2017
First Award
2020
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

80 8th Avenue Suite 202
New York, NY 10011
   (646) 262-4118
   N/A
   www.sparkneuro.com
Location: Single
Congr. District: 10
County: New York

Public Profile

SPARK Neuro personnel define themselves as a neuroscience company in the business of quantifying brain data for better clinical care and therapeutic discovery. The firm seems to have begun operations with a very different focus initially addressing how to measure emotion and attention to optimize how successful a commerical or movie trailer could be - employing their then new technology to reveal how long someone could be engaged with second-by-second precision, providing more accurate data points to provide to their then clients.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
15-19
Revenue Range
1.5M-2M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 2 AF $2,799,996
Project Title: SPARK Neuro TBI Detection Tool
2022 1 NIH $299,786
Project Title: Improving an EEG-based neurodiagnostic software platform to detect Alzheimer's Disease in MCI patients
2020 2 AF $999,994
Project Title: SPARK Neuro Familiarity Detector
0 1 NIH $1,314,973
Project Title: Developing a novel EEG-based index for evaluating amyloid and tau burden in Alzheimer's Disease

Key People / Management

  Che Lucero

  Ryan Mcgarry

Company News

There are no news available.